Lanreotide

Common brands: Somatuline Depot, Vitamin D, Xermelo, Synthroid, Metformin Hydrochloride

Top reporter: Ipsen Biopharmaceuticals, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Provitamin D2 Compound [EPC]Corticosteroid [EPC]Dihydropyridine Calcium Channel Blocker [EPC]HMG-CoA Reductase Inhibitor [EPC]
7,618
Total Reports
2,424
Serious Reports
1,352
Death Reports
30
Reported Reactions
Death Report Ratio: High (17.75%)

Patient Demographics

Male
3,273
Female
3,995

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Lanreotide.

# Reaction Reports % of Total
1 OFF LABEL USE 1,409
10.1%
2 DIARRHOEA 1,382
9.9%
3 DEATH 1,163
8.4%
4 FATIGUE 930
6.7%
5 NAUSEA 698
5.0%
6 INJECTION SITE PAIN 577
4.2%
7 ABDOMINAL PAIN 550
4.0%
8 HEADACHE 485
3.5%
9 MALAISE 422
3.0%
10 DIZZINESS 402
2.9%
11 ASTHENIA 397
2.9%
12 PAIN 379
2.7%
13 WEIGHT DECREASED 374
2.7%
14 INJECTION SITE MASS 365
2.6%
15 PRODUCT DOSE OMISSION ISSUE 363
2.6%
16 VOMITING 350
2.5%
17 DRUG INEFFECTIVE 322
2.3%
18 MALIGNANT NEOPLASM PROGRESSION 316
2.3%
19 ABDOMINAL PAIN UPPER 302
2.2%
20 CONSTIPATION 291
2.1%
21 DECREASED APPETITE 263
1.9%
22 FLATULENCE 261
1.9%
23 ARTHRALGIA 259
1.9%
24 ABDOMINAL DISTENSION 252
1.8%
25 ABDOMINAL DISCOMFORT 251
1.8%
26 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 242
1.7%
27 DYSPNOEA 233
1.7%
28 BLOOD GLUCOSE INCREASED 224
1.6%
29 HYPERTENSION 220
1.6%
30 ALOPECIA 214
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.